Many people in the world have trouble sleeping one way or another, and sometimes the food that is eaten can contribute to that. But, a new report reveals a kind of diet people can follow to be able to sleep better.
Express reports that a diet that is high in fat but low in carbohydrates can help a person get a good night’s sleep. Too little sleep can be bad for a person’s health in the long run, so it’s important to be able to get the 7-8 hours of sleeping time to be healthy. Diet also plays a part in how well a person is able to sleep, and some studies have shown that while eating a high-carb diet may help a person to sleep, it will not be as good. Another study suggests that lowering carbs and eating high-fat meals at dinner will help.
Other studies have backed up the associations with the diet and quality of sleep, suggesting that a high-carb and low-fat diet greatly lowered a person’s quality of sleep compared to a low-carb high-fat diet with the same calorie count.
A low-carb, high-fat diet is mainly made up of nuts, cheese such as cottage cheese, meat, fish, dairies such as butter and eggs, fruits like avocadoes, oils, and seeds. Nuts, in particular, contain melatonin, which is a hormone in the body that helps regulate the sleep cycle. This hormone increases the blood levels in the body, resulting in better sleep. The rest of the foods mentioned that have lean protein contain the amino acid called tryptophan, which can increase the levels of serotonin in the brain, resulting in a good night’s sleep as well.
Other eating habits that can promote a good night’s sleep according to Sleep.org is to also reduce sugar or added sugars intake in the food you eat at dinner. Taking B vitamin supplements can also add to the regulation of melatonin in the body and thus helping you get a better night’s sleep. Following this kind of diet will also lead to overall weight loss, and losing weight also means better sleep.


Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 



